ABT-263 (Navitoclax) 100mg | 98.02%
APEXBIO TECHNOLOGY LLC
Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w Apoptosis|Bcl-2 Family
More Information Supplier PageABT-263 (Navitoclax)
Search Results
(-)-(S)-B-973B 5 mg | 99.52%
TargetMol
(-)-(S)-B-973B is an effective allosteric agonist and a positive allosteric modulator of α7 nAChR.
More Information Supplier Page(-)-(S)-B-973B
(-)-(S)-B-973B 10 mg | 99.52%
TargetMol
(-)-(S)-B-973B is an effective allosteric agonist and a positive allosteric modulator of α7 nAChR.
More Information Supplier Page(-)-(S)-B-973B
(-)-(S)-B-973B 25 mg | 99.52%
TargetMol
(-)-(S)-B-973B is an effective allosteric agonist and a positive allosteric modulator of α7 nAChR.
More Information Supplier Page(-)-(S)-B-973B
(-)-(S)-B-973B 50 mg | 99.52%
TargetMol
(-)-(S)-B-973B is an effective allosteric agonist and a positive allosteric modulator of α7 nAChR.
More Information Supplier Page(-)-(S)-B-973B
(-)-(S)-Cibenzoline 5 mg | Purity Not Available
TargetMol
(-)-(S)-Cibenzoline (Escibenzoline), a S(+)-enantiomer of Cibenzoline, is an antiarrhythmic agent.
More Information Supplier Page(-)-(S)-Cibenzoline-[d4] Please inquire | Purity Not Available
BOC Sciences
(-)-(S)-Cibenzoline-[d4], is the labelled analogue of Cibenzoline. Cibenzoline is a Class Ia antiarrhythmic.
More Information Supplier Page(-)-(S)-Equol 25 mg | 99.61%
TargetMol
(-)-(S)-Equol (4′,7-Dihydroxyisoflavan) is an orally bioavailable, non-steroidal estrogen naturally produced by the metabolism of the isoflavonoid daidzein by human intestinal microflora, with potential chemoprotective and estrogen receptor (ER) modulating activities. S-equol preferentially binds to and activates the beta isoform of ER in certain target tissues, while having an antagonistic effect in other tissues. This modulates […]
More Information Supplier Page(-)-(S)-Equol
(-)-(S)-Equol 5 mg | 99.61%
TargetMol
(-)-(S)-Equol (4′,7-Dihydroxyisoflavan) is an orally bioavailable, non-steroidal estrogen naturally produced by the metabolism of the isoflavonoid daidzein by human intestinal microflora, with potential chemoprotective and estrogen receptor (ER) modulating activities. S-equol preferentially binds to and activates the beta isoform of ER in certain target tissues, while having an antagonistic effect in other tissues. This modulates […]
More Information Supplier Page(-)-(S)-Equol
(-)-(S)-Equol 1 mL | 99.61%
TargetMol
(-)-(S)-Equol (4′,7-Dihydroxyisoflavan) is an orally bioavailable, non-steroidal estrogen naturally produced by the metabolism of the isoflavonoid daidzein by human intestinal microflora, with potential chemoprotective and estrogen receptor (ER) modulating activities. S-equol preferentially binds to and activates the beta isoform of ER in certain target tissues, while having an antagonistic effect in other tissues. This modulates […]
More Information Supplier Page(-)-(S)-Equol
(-)-(S)-Equol 500 mg | 99.61%
TargetMol
(-)-(S)-Equol (4′,7-Dihydroxyisoflavan) is an orally bioavailable, non-steroidal estrogen naturally produced by the metabolism of the isoflavonoid daidzein by human intestinal microflora, with potential chemoprotective and estrogen receptor (ER) modulating activities. S-equol preferentially binds to and activates the beta isoform of ER in certain target tissues, while having an antagonistic effect in other tissues. This modulates […]
More Information Supplier Page(-)-(S)-Equol
